Furthermore, Cy's not obtainable by the fungus could be prepared by the enzyme system in the presence of the appropriate precursor amino acids; the synthesis of [iV-methyl-(+) The immunosuppressive effects of the new derivatives are discussed. 1283 The cyclosporins (Cy's) represent a class of cyclic undecapeptides, which possess the structure shown in Fig. 1 for CyA(Sandimmun), but differ in their amino acid composition. CyAexerts antifungal and antiparasitic, antiinflammatory and immunosuppressive activities0 and is used in transplantation surgery and the treatment of autoimmune diseases2>3).
So far twenty-four naturally occuring Cy's beside CyAhave been described4 >5) , which are modified in nine of the eleven amino acid positions. Theonly non-variable building units are sarcosine in position 3 and D-alanine (o-Ala) in position 8 of the Cy ring. In positions 6, 9 and 10, the only modification compared to CyAconsists in the lack of the iV-methyl (Me) groups in these positions. The greatest variability in the Cy molecule is observed in position 2, which can be occupied with l-2-
In addition to these natural Cy's several Cy's were obtained by precursor directed biosynthesis, 
Materials and Methods
Growth of Organism B. nivea, strain 7939/45, was maintained on agar slants (malt extract 2%, yeast extract 0.4%). Preculture fermentation was carried out as described earlier70. After 48 hours the preculture was used as inoculum for 10 flasks with 100 ml of the same medium, but containing EHCpepton (Amber, Milwaukee, U.S.A.) instead of casein pepton Tryptone (Oxoid, Wesel, FRG). After 7 days of cultivation cells were harvested by suction filtration and lyophilized.
Enzyme Preparation Enzyme preparation was performed as described7), but buffer A contained Tris-HCl 0.2 m (pH 7. Chromatographic Procedures (c/. 
Results
It was previously shown that CyAcan be synthesized in vitro by an enzymefraction of a crude extract of the fungus B. nivea, strain 7939/F70.
However the specific activity of this enzymepreparation was rather low. Wetherefore prepared an enzymefrom extracts of a high producer strain (7939/45). Fig. 2 
Leu, respectively (Fig. 2) . and shows strong immunosuppressive activity; all these data confirm the identity of CyA. In vitro synthesis of CyAhas an optimal temperature of 24°C (Fig. 3) . Since the enzyme has been proven to be much more stable at The reaction mixtures were incubated at the indicated temperatures (A). The reaction proceeded linear for about 15 minutes at 24°C (B). After 10 minutes of reaction, Cy's were extracted with 2ml ofethyl acetate. The content of radioactivity in a 100-/d aliquot of this extract was measured in a scintillation counter. 100% value was 3,591 cpm; identity of CyA was checked by TLC analysis.
lower temperature, the yields of CyA at optimal (24°C) and suboptimal (6°C) temperature were compared in incubations of long duration: The reaction stops at a CyAconcentration of about 30^g/ml when the incubation was carried out at 24°C, whereas the incubation at 6°C yields more than 50^g/ml of CyA. Therefore all incubations for preparative HPLCseparations were performed at 6°C. Amongthe natural Cy's some variations in position 1 have been detected: The deoxy-analogue in CyF and CyK, the non-iV-methylated Bmt in CyL and CyP, MeLeu in CyO and JV-methyl-L-2-aminooctanoic acid in CyZ. With the enzyme system described here, the incorporation of MeLeuin position 1 (CyO) was also possible. L-/3-Cyclohexylalanine (CyclohexylAla), a mimetic of Bmt, which has been successfully incorporated in position 1 in feeding experiments^, was also accepted by the enzyme, leading to formation of [MeCyclohexylAla^CyA as the main EtOAc-extractable reaction product. Twoother Cy's with modifications in position 1, the second of which was accessible until now only by chemical synthesis, were formed also in good yields : Dihydro-CyA* and [iV-methyl-(+)-2-amino-3-hydroxy-4,4-dimethyloctanoic acid^CyA ([MeAhdo^CyA), both cochromatographing exactly with authentic references in TLCand HPLC. The greatest variability in the Cy ring occurs at position 2. As shown previously7), the enzyme complex is able to introduce into this position the amino acids Abu, Ala, Thr, Val and Nva (Cy'sA, B, C, D and G). These Cy's were available with the enzyme preparation described here, too. Furthermore the [L-allylglycine2]CyA ([AllylGly2]CyA), which was obtained by precursor feeding to the fungus6) could also be synthesized in vitro and was identified by cochromatography with an authentic T Dihydro-CyAwas isolated from fermentations using dihydro-Bmt as precursor. (P. Bollinger and J. J.
Boelsterli (Sandoz Ltd.) ; unpublished results). The running span was 2x10cm (I) or 10cm (II and III). The a-factor is defined as relative retention time [(tBtl-t0)/(t^2-t0)] x 10 whereat tR)1 and tR,2 mean the corresponding retention times and t0 is the dead retention time. As reference compound, CyAis taken (a=10.00).
a The Rf values of this compoundwere determined after HPLCfractionation.
sample. When Nva, in place of Abu, was added in excess, the production of (Fig. 2) .
So far the Ala residue in position 7 can only be replaced by Abu in vivo, yielding CyV. The latter Cywas formed in vitro as the main reaction product, whenAla was omitted in the reaction mixture.
Recently 
Structure-activity Relationships
The structure-activity relationships of several of the Cy's described here have been discussed elsewhere4~6). Therefore only some remarks about the new Cy's listed in Table 2 
Discussion
In a previous paper7) Billich and Zocher have reported on an enzymefraction from B. nivea extracts, capable of synthesizing CyAand some homologues de novo. Using a strain of B. nivea which produces higher Cy concentrations in submerged cultures, we were able to yield highly active fractions which allowed a systematic search for biosynthesis of a wide spectrum of homologuesof CyA. Cy's were obtained in sufficient quantities to allow examination of their immunosuppressive activities.
In each case where we could adjust the proper amino acid compositions for Cy's obtained either naturally or by precursor feeding to the fungus, the expected Cy's were also produced in the in vitro system.
Moreover the enzyme system makes Cy's available, which could not be synthesized by providing the specific precursors to the fungus, as in the case of [D-Abu8]CyA and [aIle5,aMeIlen]CyA. In the fungus, these amino acids seem to be metabolized, as indicated by the fact that supplementing of dAbu increases the CyAproduction.
In summary, the methodology of enzymatic in v/Yra-synthesis enabled directed modifications, so far, in positions 1, 2, 5, 7, 8 and ll of the CyA peptide ring.
